TAIM
AVNS icon

TD Ameritrade Investment Management’s Avanos Medical AVNS Stock Holding History

TD Ameritrade Investment Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-36
Closed -$1K – 34
2023
Q2 		$1K Hold
36
– – ﹤0.01% 493
2023
Q1 		$1K Hold
36
– – ﹤0.01% 532
2022
Q4 		$1K Sell
36
-17
-32% -$416 ﹤0.01% 533
2022
Q3 		$1K Sell
53
-15
-22% -$392 ﹤0.01% 539
2022
Q2 		$2K Hold
68
– – ﹤0.01% 528
2022
Q1 		$2K Buy
68
+15
+28% +$483 ﹤0.01% 592
2021
Q4 		$2K Buy
+53
New +$1.71K ﹤0.01% 580

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TD Ameritrade Investment Management's AVNS Position: Q3 2023 in Review

TD Ameritrade Investment Management sold out of Avanos Medical (AVNS) in Q3 2023, closing a stake of 36 shares — an estimated $1K sold.

TD Ameritrade Investment Management first reported a position in AVNS in Q4 2021 and held it in 7 quarters. The position peaked at $2K in Q2 2022. 260 funds tracked by Wall St. Rank hold AVNS as of Q3 2023.

  • TD Ameritrade Investment Management reported no remaining Avanos Medical position as of Q3 2023 after selling out during the quarter.
  • TD Ameritrade Investment Management sold 36 Avanos Medical shares in Q3 2023, an estimated $1K.
  • TD Ameritrade Investment Management first reported a position in Avanos Medical in Q4 2021 and held it in 7 quarters.
  • TD Ameritrade Investment Management's Avanos Medical position peaked at $2K in Q2 2022.
  • 260 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2023.

Based on TD Ameritrade Investment Management's 13F filing for Q3 2023.